The following Structured Product Label (SPL) was submitted to the FDA by Apex Energetics Inc. for the product R08 (NDC 63479-1808). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, uses:, otc - pregnancy or breast feeding, other safety information, otc - keep out of reach of children, otc - stop use, directions:, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active Ingredients | |
Adenosine Triphosphate | 5X |
Ammonium Muriaticum | 5C |
Baptisia Tinctoria | 4C |
Colchicum Autumnale | 5C 7C |
Juniperus Communis | 2X 3X 6X 8X 12X 2C 3C 5C 6C 7C |
Levothyroxine | 3C 4C |
Podophyllinum | 5C |
Rhus Toxicodendron | 3X 6X 8X 12X 2C 3C 5C 6C 7C |
For temporary relief of minor:
rash*
coughing*
sore throat*
body aches*
swelling limbs*
ear pain*
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
If pregnant or breastfeeding, ask a health professional before use.
Do not use if clear seal over the cap is broken or missing.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Stop use and ask a doctor if rash, coughing, sore throat, body aches, swelling limbs, ear pain, or other symptoms do not improve within 7 days or are accompanied by fever.
Adults & children ages 12 years and over: Take 10 drops under the tongue 3 times a day, or as directed by your healthcare professional. Consult a physician for use in children under 12 years of age.
alcohol (20% by volume), distilled water
Distributed by Apex Energetics. Questions?
16592 Hale Ave., Irvine, CA 92606, USA
FUTUREPLEX® R08
REGENRX®
LYMPHATICS
Homeopathic Formula
Rash* Coughing*
Sore Throat* Body Aches*
1 fl oz (30 mL)
Alcohol 20% by Volume
* Please review the disclaimer below.
